Showing results (161-170 of 267) with videos related to

Sort By:
Pageof 27
Cancers|August 26, 2022
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team EvaluationIrene Tizianel, Mario Caccese, Francesca Torresan, et al.
Clinical Endocrinology|December 31, 2009
Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditisDavide Nacamulli, Caterina Mian, Daniela Petricca, et al.
European Journal of Endocrinology|August 3, 2005
Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenomaMassimo Terzolo, Silvia Bovio, Anna Pia, et al.
Acta Neurochirurgica|November 25, 2017
Early recognition of aggressive pituitary adenomas: a single-centre experienceFilippo Ceccato, Daniela Regazzo, Mattia Barbot, et al.
Clinical Endocrinology|June 8, 2017
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndromeFilippo Ceccato, Laura Trementino, Mattia Barbot, et al.
Frontiers in Endocrinology|March 7, 2022
The Accuracy of Simple and Adjusted Aldosterone Indices for Assessing Selectivity and Lateralization of Adrenal Vein Sampling in the Diagnosis of Primary Aldosteronism SubtypesMirko Parasiliti-Caprino, Fabio Bioletto, Filippo Ceccato, et al.
Cancer Investigation|November 5, 2015
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical TumorsBeatrice Rubin, Halenya Monticelli, Marco Redaelli, et al.
Endocrine Journal|October 25, 2013
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cellsRaffaele Pezzani, Beatrice Rubin, Marco Redaelli, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 9, 2022
Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin DisordersChiara Sabbadin, Francesca Beggiao, Carlotta Keiko Vedolin, et al.
Pituitary|September 21, 2014
Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing?Mattia Barbot, Viviana Daidone, Marialuisa Zilio, et al.
Pageof 27